• Je něco špatně v tomto záznamu ?

Respiratory Mechanics and Outcomes in Immunocompromised Patients With ARDS: A Secondary Analysis of the EFRAIM Study

A. Demoule, M. Antonelli, P. Schellongowski, P. Pickkers, M. Soares, T. Meyhoff, J. Rello, PR. Bauer, A. van de Louw, V. Lemiale, D. Grimaldi, I. Martin-Loeches, M. Balik, S. Mehta, A. Kouatchet, A. Barratt-Due, M. Valkonen, J. Reignier, V....

. 2020 ; 158 (5) : 1947-1957. [pub] 20200620

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, multicentrická studie, pozorovací studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc21019863

BACKGROUND: In view of the high mortality rate of immunocompromised patients with ARDS, it is important to identify targets for improvement. RESEARCH QUESTION: This study investigated factors associated with mortality in this specific ARDS population, including factors related to respiratory mechanics (plateau pressure [Pplat,rs], compliance [Crs], and driving pressure [ΔPrs]). STUDY DESIGN AND METHODS: This study consisted of a predefined secondary analysis of the EFRAIM data. Overall, 789 of 1,611 patients met the Berlin criteria for ARDS, and Pplat,rs, ΔPrs, and Crs were available for 494 patients. A hierarchical model was used to assess factors at ARDS onset independently associated with hospital mortality. RESULTS: Hospital mortality was 56.3%. After adjustment, variables independently associated with hospital mortality included ARDS of undetermined etiology (OR, 1.66; 95% CI, 1.01-2.72), need for vasopressors (OR, 1.91; 95% CI, 1.27-2.88), and need for renal replacement therapy (OR, 2.02; 95% CI, 1.37-2.97). ARDS severity according to the Berlin definition, neutropenia on admission, and the type of underlying disease were not significantly associated with mortality. Before adjustment, higher Pplat,rs, higher ΔPrs, and lower Crs were associated with higher mortality. Addition of each of these individual variables to the final hierarchical model revealed a significant association with mortality: ΔPrs (OR, 1.08; 95% CI, 1.05-1.12), Pplat,rs (OR, 1.07; 95% CI, 1.04-1.11), and Crs (OR, 0.97; 95% CI, 0.95-0.98). Tidal volume was not associated with mortality. INTERPRETATION: In immunocompromised patients with ARDS, respiratory mechanics provide additional prognostic information to predictors of hospital mortality. Studies designed to define lung-protective ventilation guided by these physiological variables may be warranted in this specific population.

AP HP Groupe Hospitalier Pitié Salpêtrière Charles Foix Service de Pneumologie Médecine Intensive et Réanimation Département R3S Sorbonne Université INSERM UMRS1158 Neurophysiologie Respiratoire Expérimentale et Clinique Paris France

CIBERES Universitat Autonòma de Barcelona European Study Group of Infections in Critically Ill Patients Barcelona Spain

Critical Care Center CHU Lille School of Medicine University of Lille Lille France

Department of Anesthesia Intensive Care and Emergency Medicine Fondazione Ospedale Universitario A Gemelli IRCCS

Department of Anesthesiology and Intensive Care 1st Faculty of Medicine and General University Hospital Charles University Prague Czech Republic

Department of Critical Care and Graduate Program in Translational Medicine D'Or Institute for Research and Education Programa de Pós Graduação em Clínica Médica Rio De Janeiro Brazil

Department of Critical Care King's College Hospital NHS Foundation Trust London England

Department of Emergencies and Critical Care Oslo University Hospital Oslo Norway

Department of Intensive Care Hôpital Erasme Université Libre de Bruxelles Brussels Belgium

Department of Intensive Care Medicine Multidisciplinary Intensive Care Research Organization St James Hospital Dublin Ireland

Department of Intensive Care Medicine Radboud University Medical Center Nijmegen The Netherlands

Department of Intensive Care Rigshospitalet University of Copenhagen Copenhagen Denmark

Department of Medical Intensive Care Medicine University Hospital of Angers Angers France

Department of Medicine 1 Medical University of Vienna Vienna Austria

Department of Medicine and Interdepartmental Division of Critical Care Medicine Sinai Health System University of Toronto Toronto ON Canada

Division of Intensive Care Medicine Department of Anesthesiology Intensive Care and Pain Medicine University of Helsinki and Helsinki University Hospital Helsinki Finland

Division of Pulmonary and Critical Care Penn State University College of Medicine Hershey PA

Istituto di Anestesiologia e Rianimazione Università Cattolica del Sacro Cuore Rome Italy

Medical Intensive Care Unit APHP Hôpital Saint Louis Famirea Study Group ECSTRA Team and Clinical Epidemiology UMR 1153 Center of Epidemiology and Biostatistics Sorbonne Paris Cité CRESS INSERM Paris Diderot Sorbonne University Paris France

Medical Intensive Care Unit Hôtel Dieu HME University Hospital of Nantes Nantes France

Pulmonary and Critical Care Medicine Mayo Clinic Rochester MN

Réanimation Polyvalente et Département d'Anesthésie et de Réanimation Institut Paoli Calmettes Marseille France

Terapia Intensiva Hospital Maciel Montevideo Uruguay

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21019863
003      
CZ-PrNML
005      
20210830101448.0
007      
ta
008      
210728s2020 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.chest.2020.05.602 $2 doi
035    __
$a (PubMed)32569634
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Demoule, Alexandre $u AP-HP Groupe Hospitalier Pitié-Salpêtrière Charles Foix, Service de Pneumologie, Médecine Intensive et Réanimation, Département R3S Sorbonne Université, INSERM, UMRS1158 Neurophysiologie Respiratoire Expérimentale et Clinique, Paris, France. Electronic address: alexandre.demoule@aphp.fr
245    10
$a Respiratory Mechanics and Outcomes in Immunocompromised Patients With ARDS: A Secondary Analysis of the EFRAIM Study / $c A. Demoule, M. Antonelli, P. Schellongowski, P. Pickkers, M. Soares, T. Meyhoff, J. Rello, PR. Bauer, A. van de Louw, V. Lemiale, D. Grimaldi, I. Martin-Loeches, M. Balik, S. Mehta, A. Kouatchet, A. Barratt-Due, M. Valkonen, J. Reignier, V. Metaxa, AS. Moreau, G. Burghi, D. Mokart, J. Mayaux, M. Darmon, E. Azoulay, EFRAIM Investigators
520    9_
$a BACKGROUND: In view of the high mortality rate of immunocompromised patients with ARDS, it is important to identify targets for improvement. RESEARCH QUESTION: This study investigated factors associated with mortality in this specific ARDS population, including factors related to respiratory mechanics (plateau pressure [Pplat,rs], compliance [Crs], and driving pressure [ΔPrs]). STUDY DESIGN AND METHODS: This study consisted of a predefined secondary analysis of the EFRAIM data. Overall, 789 of 1,611 patients met the Berlin criteria for ARDS, and Pplat,rs, ΔPrs, and Crs were available for 494 patients. A hierarchical model was used to assess factors at ARDS onset independently associated with hospital mortality. RESULTS: Hospital mortality was 56.3%. After adjustment, variables independently associated with hospital mortality included ARDS of undetermined etiology (OR, 1.66; 95% CI, 1.01-2.72), need for vasopressors (OR, 1.91; 95% CI, 1.27-2.88), and need for renal replacement therapy (OR, 2.02; 95% CI, 1.37-2.97). ARDS severity according to the Berlin definition, neutropenia on admission, and the type of underlying disease were not significantly associated with mortality. Before adjustment, higher Pplat,rs, higher ΔPrs, and lower Crs were associated with higher mortality. Addition of each of these individual variables to the final hierarchical model revealed a significant association with mortality: ΔPrs (OR, 1.08; 95% CI, 1.05-1.12), Pplat,rs (OR, 1.07; 95% CI, 1.04-1.11), and Crs (OR, 0.97; 95% CI, 0.95-0.98). Tidal volume was not associated with mortality. INTERPRETATION: In immunocompromised patients with ARDS, respiratory mechanics provide additional prognostic information to predictors of hospital mortality. Studies designed to define lung-protective ventilation guided by these physiological variables may be warranted in this specific population.
650    _2
$a senioři $7 D000368
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a následné studie $7 D005500
650    _2
$a lidé $7 D006801
650    12
$a imunokompromitovaný pacient $7 D016867
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a ventilace umělá s výdechovým přetlakem $x metody $7 D011175
650    _2
$a prognóza $7 D011379
650    _2
$a prospektivní studie $7 D011446
650    _2
$a syndrom dechové tísně $x imunologie $x patofyziologie $x terapie $7 D012128
650    _2
$a mechanika dýchání $x fyziologie $7 D015656
650    _2
$a dechový objem $x fyziologie $7 D013990
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
655    _2
$a pozorovací studie $7 D064888
700    1_
$a Antonelli, Massimo $u Department of Anesthesia, Intensive Care and Emergency Medicine, Fondazione Ospedale Universitario A. Gemelli IRCCS; Istituto di Anestesiologia e Rianimazione Università Cattolica del Sacro Cuore, Rome, Italy
700    1_
$a Schellongowski, Peter $u Department of Medicine I, Medical University of Vienna, Vienna, Austria
700    1_
$a Pickkers, Peter $u Department of Intensive Care Medicine (710), Radboud University Medical Center, Nijmegen, The Netherlands
700    1_
$a Soares, Marcio $u Department of Critical Care and Graduate Program in Translational Medicine, D'Or Institute for Research and Education, Programa de Pós-Graduação em Clínica Médica, Rio De Janeiro, Brazil
700    1_
$a Meyhoff, Tine $u Department of Intensive Care, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
700    1_
$a Rello, Jordi $u CIBERES, Universitat Autonòma de Barcelona, European Study Group of Infections in Critically Ill Patients (ESGCIP), Barcelona, Spain
700    1_
$a Bauer, Philippe R $u Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN
700    1_
$a van de Louw, Andry $u Division of Pulmonary and Critical Care, Penn State University College of Medicine, Hershey, PA
700    1_
$a Lemiale, Virgine $u Medical Intensive Care Unit, APHP, Hôpital Saint-Louis, Famirea Study Group, ECSTRA Team, and Clinical Epidemiology, UMR 1153, Center of Epidemiology and Biostatistics, Sorbonne Paris Cité, CRESS, INSERM, Paris Diderot Sorbonne University, Paris, France
700    1_
$a Grimaldi, David $u Department of Intensive Care, Hôpital Erasme, Université Libre de Bruxelles (ULB), Brussels, Belgium
700    1_
$a Martin-Loeches, Ignacio $u Department of Intensive Care Medicine, Multidisciplinary Intensive Care Research Organization (MICRO) and Department of Clinical Medicine, Trinity College, Wellcome Trust-HRB Clinical Research Facility, Caring for Critically Ill Immuno-compromised Patients Multinational Network (Nine-I). St James Hospital, Dublin, Ireland
700    1_
$a Balik, Martin $u Department of Anesthesiology and Intensive Care, 1st Faculty of Medicine and General University Hospital, Charles University, Prague, Czech Republic
700    1_
$a Mehta, Sangeeta $u Department of Medicine and Interdepartmental Division of Critical Care Medicine, Sinai Health System, University of Toronto, Toronto, ON, Canada
700    1_
$a Kouatchet, Achille $u Department of Medical Intensive Care Medicine, University Hospital of Angers, Angers, France
700    1_
$a Barratt-Due, Andreas $u Department of Emergencies and Critical Care, Oslo University Hospital, Oslo, Norway
700    1_
$a Valkonen, Miia $u Division of Intensive Care Medicine, Department of Anesthesiology, Intensive Care and Pain Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
700    1_
$a Reignier, Jean $u Medical Intensive Care Unit, Hôtel Dieu-HME University Hospital of Nantes, Nantes, France
700    1_
$a Metaxa, Victoria $u Department of Critical Care, King's College Hospital, NHS Foundation Trust, London, England
700    1_
$a Moreau, Anne-Sophie $u Critical Care Center, CHU Lille, School of Medicine, University of Lille, Lille, France
700    1_
$a Burghi, Gaston $u Terapia Intensiva, Hospital Maciel, Montevideo, Uruguay
700    1_
$a Mokart, Djamel $u Réanimation Polyvalente et Département d'Anesthésie et de Réanimation, Institut Paoli-Calmettes, Marseille, France
700    1_
$a Mayaux, Julien $u AP-HP Groupe Hospitalier Pitié-Salpêtrière Charles Foix, Service de Pneumologie, Médecine Intensive et Réanimation, Département R3S Sorbonne Université, INSERM, UMRS1158 Neurophysiologie Respiratoire Expérimentale et Clinique, Paris, France
700    1_
$a Darmon, Michael $u Division of Pulmonary and Critical Care, Penn State University College of Medicine, Hershey, PA
700    1_
$a Azoulay, Elie $u Division of Pulmonary and Critical Care, Penn State University College of Medicine, Hershey, PA
710    2_
$a EFRAIM Investigators
773    0_
$w MED00002127 $t Chest $x 1931-3543 $g Roč. 158, č. 5 (2020), s. 1947-1957
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32569634 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20210830101448 $b ABA008
999    __
$a ok $b bmc $g 1690628 $s 1140309
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 158 $c 5 $d 1947-1957 $e 20200620 $i 1931-3543 $m Chest $n Chest $x MED00002127
LZP    __
$a Pubmed-20210728

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...